Stock Track | Cellebrite Stock Plummets 10.87% Despite Strong Q4 Results and Upbeat Outlook

Stock Track

13 Feb

Cellebrite DI Ltd (NASDAQ: CLBT), a leading provider of digital intelligence solutions, saw its stock price plummet by 10.87% in pre-market trading on Thursday, February 13, 2025, despite reporting solid fourth-quarter and full-year 2024 financial results.

For the fourth quarter of 2024, Cellebrite reported adjusted earnings of $0.10 per share, meeting analyst expectations. The company's revenue rose 17.2% year-over-year to $109 million, surpassing analyst estimates of $107.18 million. This strong performance was driven by a 21% increase in subscription revenue.

For the full year 2024, Cellebrite's revenue reached $401.2 million, up 23% from the previous year. The company achieved an adjusted EBITDA margin of 24.8%, showcasing its ability to generate robust profitability and cash flow.

Looking ahead, Cellebrite provided an optimistic outlook for the first quarter of 2025 and the full year. The company expects revenue in the range of $480 million to $490 million for 2025, representing a growth of 20% to 22% compared to 2024. Additionally, Cellebrite forecasts an adjusted EBITDA margin of 24% to 25% for the full year.

Despite the strong financial performance and positive guidance, Cellebrite's stock price experienced a significant decline, suggesting a potential overreaction from the market. Analysts and industry experts have praised the company's execution and its ability to capitalize on the growing demand for digital intelligence solutions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/news/1171347410"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1171347410\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1171347410?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-13 23:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171347410","market":"us","top_or_hot":-1,"title":"Stock Track | Cellebrite Stock Plummets 10.87% Despite Strong Q4 Results and Upbeat Outlook","media":"Stock Track","content":"<html><body><p>Cellebrite DI Ltd (NASDAQ: CLBT), a leading provider of digital intelligence solutions, saw its stock price plummet by 10.87% in pre-market trading on Thursday, February 13, 2025, despite reporting solid fourth-quarter and full-year 2024 financial results.</p>\n<p>For the fourth quarter of 2024, Cellebrite reported adjusted earnings of $0.10 per share, meeting analyst expectations. The company's revenue rose 17.2% year-over-year to $109 million, surpassing analyst estimates of $107.18 million. This strong performance was driven by a 21% increase in subscription revenue.</p>\n<p>For the full year 2024, Cellebrite's revenue reached $401.2 million, up 23% from the previous year. The company achieved an adjusted EBITDA margin of 24.8%, showcasing its ability to generate robust profitability and cash flow.</p>\n<p>Looking ahead, Cellebrite provided an optimistic outlook for the first quarter of 2025 and the full year. The company expects revenue in the range of $480 million to $490 million for 2025, representing a growth of 20% to 22% compared to 2024. Additionally, Cellebrite forecasts an adjusted EBITDA margin of 24% to 25% for the full year.</p>\n<p>Despite the strong financial performance and positive guidance, Cellebrite's stock price experienced a significant decline, suggesting a potential overreaction from the market. Analysts and industry experts have praised the company's execution and its ability to capitalize on the growing demand for digital intelligence solutions.</p></body></html>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Stock Track | Cellebrite Stock Plummets 10.87% Despite Strong Q4 Results and Upbeat Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Cellebrite Stock Plummets 10.87% Despite Strong Q4 Results and Upbeat Outlook\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-13 23:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Cellebrite DI Ltd (NASDAQ: CLBT), a leading provider of digital intelligence solutions, saw its stock price plummet by 10.87% in pre-market trading on Thursday, February 13, 2025, despite reporting solid fourth-quarter and full-year 2024 financial results.</p>\n<p>For the fourth quarter of 2024, Cellebrite reported adjusted earnings of $0.10 per share, meeting analyst expectations. The company's revenue rose 17.2% year-over-year to $109 million, surpassing analyst estimates of $107.18 million. This strong performance was driven by a 21% increase in subscription revenue.</p>\n<p>For the full year 2024, Cellebrite's revenue reached $401.2 million, up 23% from the previous year. The company achieved an adjusted EBITDA margin of 24.8%, showcasing its ability to generate robust profitability and cash flow.</p>\n<p>Looking ahead, Cellebrite provided an optimistic outlook for the first quarter of 2025 and the full year. The company expects revenue in the range of $480 million to $490 million for 2025, representing a growth of 20% to 22% compared to 2024. Additionally, Cellebrite forecasts an adjusted EBITDA margin of 24% to 25% for the full year.</p>\n<p>Despite the strong financial performance and positive guidance, Cellebrite's stock price experienced a significant decline, suggesting a potential overreaction from the market. Analysts and industry experts have praised the company's execution and its ability to capitalize on the growing demand for digital intelligence solutions.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLBT","symbol_name":"Cellebrite","start_time":0,"source_url":"","article_id":"1171347410","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171347410","pubTimestamp":1739459252,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Cellebrite DI Ltd , a leading provider of digital intelligence solutions, saw its stock price plummet by 10.87% in pre-market trading on Thursday, February 13, 2025, despite reporting solid fourth-quarter and full-year 2024 financial results.For the fourth quarter of 2024, Cellebrite reported adjusted earnings of $0.10 per share, meeting analyst expectations. The company's revenue rose 17.2% year-over-year to $109 million, surpassing analyst estimates of $107.18 million. This strong performance ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLBT":"Cellebrite"},"translate_title":"尽管第四季度业绩强劲且前景乐观，Cellebrite股价仍暴跌10.87%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLBT":1},"content_text":"Cellebrite DI Ltd (NASDAQ: CLBT), a leading provider of digital intelligence solutions, saw its stock price plummet by 10.87% in pre-market trading on Thursday, February 13, 2025, despite reporting solid fourth-quarter and full-year 2024 financial results.\nFor the fourth quarter of 2024, Cellebrite reported adjusted earnings of $0.10 per share, meeting analyst expectations. The company's revenue rose 17.2% year-over-year to $109 million, surpassing analyst estimates of $107.18 million. This strong performance was driven by a 21% increase in subscription revenue.\nFor the full year 2024, Cellebrite's revenue reached $401.2 million, up 23% from the previous year. The company achieved an adjusted EBITDA margin of 24.8%, showcasing its ability to generate robust profitability and cash flow.\nLooking ahead, Cellebrite provided an optimistic outlook for the first quarter of 2025 and the full year. The company expects revenue in the range of $480 million to $490 million for 2025, representing a growth of 20% to 22% compared to 2024. Additionally, Cellebrite forecasts an adjusted EBITDA margin of 24% to 25% for the full year.\nDespite the strong financial performance and positive guidance, Cellebrite's stock price experienced a significant decline, suggesting a potential overreaction from the market. Analysts and industry experts have praised the company's execution and its ability to capitalize on the growing demand for digital intelligence solutions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}